Cargando…
Intravenously Administered Anti-recoverin Antibody Alone Does Not Pass through the Blood-Retinal Barrier
PURPOSE: Cancer-associated retinopathy is a paraneoplastic retinal degeneration which may primarily result from auto-immune mediated apoptosis. It has been hypothesized that high titer of auto-antibodies are able to cross the blood-retinal barrier (BRB) and to enter retinal cells to activate apoptot...
Autores principales: | Kim, Jeong Hun, Kim, Jin Hyoung, Kim, Dong Hun, Park, Woong-Yang, Kim, Kyu-Won, Yu, Young Suk |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102823/ https://www.ncbi.nlm.nih.gov/pubmed/21655045 http://dx.doi.org/10.3341/kjo.2011.25.3.189 |
Ejemplares similares
-
The intravenously administered palonosetron does not affect the spinal anesthesia
por: Kim, Myoung-Hun, et al.
Publicado: (2013) -
Recoverin Regulates Light-dependent Phosphodiesterase Activity in Retinal Rods
por: Makino, Clint L., et al.
Publicado: (2004) -
The Binding Properties and Physiological Functions of Recoverin
por: Zang, Jingjing, et al.
Publicado: (2018) -
Anti-recoverin antibody positive Heidenhain variant CJD: a case report
por: Chung, Chi-Ting, et al.
Publicado: (2023) -
Recoverin depletion accelerates cone photoresponse recovery
por: Zang, Jingjing, et al.
Publicado: (2015)